SCHEMBL31662956

SCHEMBL31662956

CC(C)(C)OC(=O)Nc1ccc(C=O)c(C2CC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA9 Q16790 1/20 0.47
DGAT1 O75907 2/20 0.45
SIRT2 Q8IXJ6 3/20 0.42
SIRT1 Q96EB6 2/20 0.42
MAP4K4 O95819 1/20 0.41
CYP17A1 P05093 1/20 0.41
CHRM1 P11229 1/20 0.40
MAPKAPK2 P49137 1/20 0.39
ACSS2 Q9NR19 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
SLC10A2 Q12908 1/20 0.38
RORC P51449 2/20 0.38
ACHE P22303 1/20 0.38
BACE1 P56817 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31406453 0.82 CA12 (0.55) CA12CA1CA9DGAT1SIRT2
SCHEMBL17920282 0.82 DGAT1 (0.47) CA12CA1CA9DGAT1SIRT2
SCHEMBL5891978 0.80 CA12 (0.49) CA12CA1CA9MAP4K4CYP17A1
SCHEMBL25894545 0.80 DGAT1 (0.45) CA12CA1CA9DGAT1SIRT2
SCHEMBL23298925 0.79 SIRT2 (0.48) CA12CA1CA9DGAT1SIRT2
SCHEMBL13014981 0.79 CA12 (0.46) CA12CA1CA9DGAT1SIRT2
SCHEMBL29880812 0.79 SIRT2 (0.48) CA12CA1CA9DGAT1SIRT2
SCHEMBL29955042 0.79 CA12 (0.48) CA12CA1CA9MAP4K4CYP17A1
SCHEMBL31662881 0.79 CA12 (0.48) CA12CA1CA9MAP4K4CYP17A1
SCHEMBL29956706 0.79 CA12 (0.48) CA12CA1CA9MAP4K4CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025149498-A1 BENZYLPIPERIDINE DERIVATIVES AS TRP4 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES ASTRAZENECA AB (SE) 2025-07-17 WO disclosed